EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieValidierungsstudieOpen Access · CC BY-NC-ND 4.0

Prospective Multicenter Evaluation of the MDS “Suggestive of PSP ” Diagnostic Criteria

Andrea Quattrone iD, Nicolai Franzmeier, Johannes Levin, Gabor C Petzold, Annika Spottke, Frederic Brosseron, Björn Falkenburger, Johannes Prudlo, Thomas Gasser, DESCRIBE‐PSP Group, The ProPSP Group, Günter U Höglinger

Movement Disorders · 2025

DOI: 10.1002/mds.30112 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Movement Disorders, 2025. Verfasst von Andrea Quattrone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The recent Movement Disorders Society (MDS)‐progressive supranuclear palsy (PSP) diagnostic criteria conceptualized three clinical diagnostic certainty levels: “suggestive of PSP” for sensitive early diagnosis based on subtle clinical signs, “possible PSP” balancing sensitivity and specificity, and “probable PSP” highly specific for PSP pathology.

Objective

The aim of this study was to prospectively validate the criteria against long‐term clinical follow‐up and characterize the diagnostic certainty increase over time.

Methods

Patients with “possible PSP” or “suggestive of PSP” diagnosis and clinical follow‐up were recruited in two German multicenter longitudinal observational studies (ProPSP and DescribePSP). The cumulative percentage of patients longitudinally increasing diagnostic certainty was assessed over up to 2.5 years of follow‐up. The sample size per arm required to detect 30% attenuated rate in diagnostic certainty increase in trials was estimated over multiple time intervals.

Results

Of 254 patients with available longitudinal data, 61 patients had low diagnostic certainty at baseline (48 suggestive of PSP, 13 possible PSP) and multiple clinical visits (median: 3, range: 2–4). The cumulative percentage of patients increasing diagnostic certainty progressed with follow‐up duration (30.4% at 6 months, 51.7% at 1 year, 80.4% at 2.5 years). The sample size required to detect 30% reduction in diagnostic certainty increase rate within 1 year was 163, slightly smaller than that required using the PSP rating scale.

Conclusions

Most “suggestive of PSP” patients increased diagnostic certainty upon longitudinal follow‐up, providing the first prospective multicenter validation of MDS‐PSP diagnostic criteria. Our data support the design of trials tailored for these early‐stage patients, suggesting the PSP rating scale and the diagnostic certainty increase rate as potential endpoint measures. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveAgedAged, 80 and overFemaleHumansMaleMiddle AgedLongitudinal StudiesProspective Studies

Stichwörter der Autor:innen

diagnostic criterialongitudinalprogressive supranuclear palsysuggestive of PSPvalidation

Autor:innen und Institutionen

  • Department of Neurology, LMU University Hospital, Ludwig-Maximilians-Universität (LMU) München, Munich, Germany.
  • Department of Medical and Surgical Sciences, Institute of Neurology, Magna Graecia University, Catanzaro, Italy.
  • Neuroscience Research Centre, Magna Graecia University, Catanzaro, Italy.
  • Institute for Stroke and Dementia Research (ISD), University Hospital, LMU, Munich, Germany.
  • Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.

ORCID-Profile: Andrea Quattrone

Zitieren

APA

Quattrone, A., Franzmeier, N., Levin, J., Petzold, G. C., Spottke, A., Brosseron, F., Falkenburger, B., Prudlo, J., Gasser, T., DESCRIBE‐PSP Group, The ProPSP Group, & Höglinger, G. U. (2025). Prospective Multicenter Evaluation of the MDS “Suggestive of PSP ” Diagnostic Criteria. Movement Disorders. https://doi.org/10.1002/mds.30112

Vancouver

Quattrone A, Franzmeier N, Levin J, Petzold GC, Spottke A, Brosseron F, et al. Prospective Multicenter Evaluation of the MDS “Suggestive of PSP ” Diagnostic Criteria. Movement Disorders. 2025. doi:10.1002/mds.30112

BibTeX
@article{Quattrone2025,
  author = {Quattrone, Andrea and Franzmeier, Nicolai and Levin, Johannes and Petzold, Gabor C and Spottke, Annika and Brosseron, Frederic and Falkenburger, Björn and Prudlo, Johannes and Gasser, Thomas and DESCRIBE‐PSP Group, The ProPSP Group, DESCRIBE‐PSP Group, The ProPSP Group and Höglinger, Günter U},
  title = {Prospective Multicenter Evaluation of the MDS “Suggestive of PSP ” Diagnostic Criteria},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30112}
}
Kostenlos starten →